Clinical Trials Browser

INDUSTRY × Disease × Genitourinary × Clear all

NCT07454603 2026-03-06

PROSTest_STRAT

Not yet recruiting

Disease, Prostatic Neoplasms

NCT04186845 2025-09-22

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Phase 3 Completed

391 enrolled 30 charts

Disease, Prostatic Neoplasms

NCT06607783 2025-08-28

PREDICT

Not yet recruiting

Disease, Prostatic Neoplasms

NCT03957252 2025-05-30

APCaRI-05

Active not recruiting

Disease, Prostatic Neoplasms

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Disease, Prostatic Neoplasms

NCT04661176 2023-10-25

Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico

Disease, Prostatic Neoplasms

NCT02981368 2021-08-09

OSPREY

Phase 2/3 Completed

385 enrolled 20 charts

Disease, Prostatic Neoplasms

NCT03335059 2020-04-15

RITE-USA

Phase 3 Terminated

Urinary Bladder Neoplasms, Disease

NCT02524860 2017-03-16

Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device

Phase NA Unknown

Disease, Prostatic Neoplasms

NCT00571675 2010-11-09

A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Completed

Disease, Neoplasm Metastasis, Prostatic Neoplasms